Pediatrix Medical Group
(NYSE) MD
Pediatrix Medical Group Financials at a Glance
Market Cap
$1.70B
Revenue (TTM)
$1.91B
Net Income (TTM)
$165.39M
EPS (TTM)
$1.94
P/E Ratio
10.58
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$20.51
Volume
790,890
Open
$20.91
Price
$20.51
Volume
790,890
Open
$20.91
Previous Close
$20.50
Daily Range
$20.46 - $20.91
52-Week Range
$11.84 - $24.99
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$20.51
Volume
790,890
Open
$20.91
Previous Close
$20.50
Daily Range
$20.46 - $20.91
52-Week Range
$11.84 - $24.99
MD News
Why Mednax Is Crashing 21.2% Today
MD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pediatrix Medical Group
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
6,575
CEO
Mark S. Ordan, MBA
Website
www.pediatrix.comHeadquarters
Sunrise, FL 33323, US
MD Financials
Key Financial Metrics (TTM)
Gross Margin
26%
Operating Margin
11%
Net Income Margin
9%
Return on Equity
20%
Return on Capital
12%
Return on Assets
7%
Earnings Yield
9.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.70B
Shares Outstanding
83.00M
Volume
790.89K
Short Interest
0.00%
Avg. Volume
799.89K
Financials (TTM)
Gross Profit
$471.88M
Operating Income
$231.09M
EBITDA
$274.22M
Operating Cash Flow
$271.09M
Capital Expenditure
$18.46M
Free Cash Flow
$252.63M
Cash & ST Invst.
$499.72M
Total Debt
$660.30M
Pediatrix Medical Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$493.77M
-1.7%
Gross Profit
$120.35M
-6.4%
Gross Margin
24.37%
N/A
Market Cap
$1.70B
N/A
Market Cap/Employee
$412.99K
N/A
Employees
4,120
N/A
Net Income
$33.68M
+10.5%
EBITDA
$59.97M
+20.1%
Quarterly Fundamentals
Net Cash
$160.58M
+48.8%
Accounts Receivable
$242.31M
-11.1%
Inventory
$0.00
N/A
Long Term Debt
$623.48M
-0.9%
Short Term Debt
$38.40M
+15.5%
Return on Assets
7.36%
N/A
Return on Invested Capital
12.01%
N/A
Free Cash Flow
$108.81M
-16.0%
Operating Cash Flow
$114.10M
-14.2%